logo-loader
NASDAQ:EOLS

Evolus

Receive alerts
Market:
NASDAQ
Price
14.00 USD
Day Change
1.08%
Market Cap:
$860.97 m
52 weeks high
15.43
52 weeks low
7.08

In brief

Evolus is a performance beauty company with a customer-centric approach focused on delivering breakthrough products in the self-pay aesthetic market. Our first commercial product is Jeuveau®, a proprietary neurotoxin formulation used in adults to temporarily improve the appearance of moderate to severe frown lines between the eyebrows (glabellar lines). Supported by a unique business model and focus on the millennial demographic, Evolus is increasing its presence in the fast-growing aesthetic neurotoxin market while pursuing a strategy of becoming a leading, multi-product aesthetics company.